Apr 25 2022

Halberd CEO Letter

By |2022-04-24T18:20:33-04:00April 25th, 2022|Featured, Investor News, News, Press Releases, Update Letter|0 Comments

Q1 Accomplishments and Q2 Plans Jackson Center, PA, April 25, 2022 Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC: HALB) This past quarter has witnessed some very significant technical and organizational achievements by the Halberd team. Q1 OVERVIEW AND ACHIEVEMENTS Halberd demonstrated elimination of the final two of the “Top Ten” antigens linked ...

Oct 7 2021

Halberd Corporation CEO Letter

By |2021-10-04T21:24:09-04:00October 7th, 2021|Featured, Investor News, News|0 Comments

Q3-21 Accomplishments and Q4 Plans Jackson Center, PA, October 7, 2021 Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC-PINK: HALB) This past quarter, Halberd has made some very significant and unparalleled achievements developing treatments for neurodegenerative diseases, such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer’s Disease, Parkinson’s Disease, etc. As ...

Oct 8 2020

Halberd Corporation CEO Update Letter – October, 2020

By |2020-10-07T19:53:21-04:00October 8th, 2020|Featured, Investor News|0 Comments

Greetings From The CEO And Staff At Halberd Corporation! (OTC-PINK: HALB) This initial CEO Letter reflects a summary of major accomplishments since I began my tenure at Halberd Corporation.  Going forward, I intend to provide update letters to our shareholders and the public on a quarterly basis. A LOOK BACK Since I began at Halberd ...

Go to Top